Search research articles
Contact Us
Filters
Showing results (201-210 of 217) with videos related to
Page
of 22
Sort By:
Nano Letters
|
January 20, 2026
RNA Resolution in an Electric Double Layer Generated by Metal-Organic Frameworks
Zhen Song, Zhi-Chao Lu, Jing-Lian Su, et al.
Journal of Atherosclerosis and Thrombosis
|
July 8, 2016
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond
Gerald F Watts, Phillip Ya Ding, Peter George, et al.
The Lancet. Oncology
|
June 9, 2024
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
Jie-Hai Yu, Bin-Yi Xiao, Dan-Dan Li, et al.
Journal of Clinical Immunology
|
August 12, 2024
The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement
Yu-Fang Lo, Shang-Yu Wang, Yi-Hui Wu, et al.
Journal of Clinical Immunology
|
August 23, 2024
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations
Wei-Te Lei, Yu-Fang Lo, Miyuki Tsumura, et al.
The Journal of Allergy and Clinical Immunology
|
November 3, 2015
Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia
Cheng-Lung Ku, Chia-Hao Lin, Su-Wei Chang, et al.
Journal of Nanobiotechnology
|
July 12, 2025
FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise
Min-Zhi Mao, Ming-Hui Zheng, Bei Guo, et al.
Signal Transduction and Targeted Therapy
|
February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
The Journal of Clinical Investigation
|
March 13, 2020
Inherited human IFN-γ deficiency underlies mycobacterial disease
Gaspard Kerner, Jérémie Rosain, Antoine Guérin, et al.
Page
of 22
Search research articles
Search
Showing results (201-210 of 217) with videos related to
Sort By:
Page
of 22
Nano Letters
|
January 20, 2026
RNA Resolution in an Electric Double Layer Generated by Metal-Organic Frameworks
Zhen Song, Zhi-Chao Lu, Jing-Lian Su, et al.
Journal of Atherosclerosis and Thrombosis
|
July 8, 2016
Translational Research for Improving the Care of Familial Hypercholesterolemia: The "Ten Countries Study" and Beyond
Gerald F Watts, Phillip Ya Ding, Peter George, et al.
The Lancet. Oncology
|
June 9, 2024
Neoadjuvant camrelizumab plus apatinib for locally advanced microsatellite instability-high or mismatch repair-deficient colorectal cancer (NEOCAP): a single-arm, open-label, phase 2 study
Jie-Hai Yu, Bin-Yi Xiao, Dan-Dan Li, et al.
Journal of Clinical Immunology
|
August 12, 2024
The Pathogenic Role of Anti-Granulocyte-Macrophage Colony-Stimulating Factor Autoantibodies in the Nocardiosis with the Central Nervous System Involvement
Yu-Fang Lo, Shang-Yu Wang, Yi-Hui Wu, et al.
Journal of Clinical Immunology
|
August 23, 2024
Immunophenotyping and Therapeutic Insights from Chronic Mucocutaneous Candidiasis Cases with STAT1 Gain-of-Function Mutations
Wei-Te Lei, Yu-Fang Lo, Miyuki Tsumura, et al.
The Journal of Allergy and Clinical Immunology
|
November 3, 2015
Anti-IFN-γ autoantibodies are strongly associated with HLA-DR*15:02/16:02 and HLA-DQ*05:01/05:02 across Southeast Asia
Cheng-Lung Ku, Chia-Hao Lin, Su-Wei Chang, et al.
Journal of Nanobiotechnology
|
July 12, 2025
FNDC5/irisin-enriched sEVs conjugated with bone-targeting aptamer alleviate osteoporosis: a potential alternative to exercise
Min-Zhi Mao, Ming-Hui Zheng, Bei Guo, et al.
Signal Transduction and Targeted Therapy
|
February 5, 2025
Perioperative tislelizumab plus chemotherapy for locally advanced gastroesophageal junction adenocarcinoma (NEOSUMMIT-03): a prospective, nonrandomized, open-label, phase 2 trial
Run-Cong Nie, Shu-Qiang Yuan, Ya Ding, et al.
Clinical & Translational Immunology
|
March 15, 2021
The efficacy and safety of the combination of axitinib and pembrolizumab-activated autologous DC-CIK cell immunotherapy for patients with advanced renal cell carcinoma: a phase 2 study
Meng-Jia Song, Qiu-Zhong Pan, Ya Ding, et al.
The Journal of Clinical Investigation
|
March 13, 2020
Inherited human IFN-γ deficiency underlies mycobacterial disease
Gaspard Kerner, Jérémie Rosain, Antoine Guérin, et al.
Page
of 22